武清龙济是主治男科-【武清龙济医院 】,武清龙济医院 ,武清龙济医院武清医院电话,龙济男子男科医院,天津武清区龙济泌尿外科医院收费高吗,武清区龙济医院龙济医院男科,天津龙济泌尿外科医院怎么走,天津性疾病医院龙济男科
武清龙济是主治男科龙济男病医院,武清区龙济医院泌尿男科,武清区龙济医院泌尿科医院在哪里,武清区龙济医院男子医院在什么地方,武清男科排名武清龙济,天津武清龙济医院属于正规医院么,天津武清区龙济男子收费怎么样
BEIJING, Dec. 4 (Xinhua) - Orthopaedic experts have warned that China should improve its prevention of orthopaedic illnesses as its population ages.Osteoporosis, bone fractures and joint diseases, to which elderly people are particularly susceptible, have surged as serious health concerns, said Feng Huicheng, surgeon-in-chief of a leading Chinese orthopaedics hospital, at the Sixth International Congress of the Chinese Orthopaedic Association (COA) Sunday in Beijing.According to China's latest census in 2010, the number of people aged 60 and over stood at 177.65 million and accounted for more than 13 percent of the country's total 1.3 billion population."Orthopaedic diseases pose a great threat to the elderly, and they'll only grow more serious as we have a large population that is aging," said Dr. Feng from the No. 309 Hospital of the People's Liberation Army."The younger generation should start to be concerned with their health now, particularly calcium loss, to prevent osteoporosis when getting old.".A report issued by the International Osteoporosis Foundation this year shows that about 70 million people in China now suffer from the condition and that number may leap to 286 million by 2020.H.K.T.Raza, president of the Asia Pacific Orthopaedic Association, said at the conference that the prevention of osteoporosis should begin when people are still young."Osteoporosis is best prevented by regular exercises and good dietary controls. All that has to be done early in life, maybe between 20 and 30, to prevent the disease," he said.According to the World Health Organization, osteoporosis remains one of the primary threats to the health of the middle-aged and elderly.Osteoporosis is the thinning of bone tissue and loss of bone density over time. Parts of the bone grow weak and prone to fracture. Women are usually subject to greater risk of osteoporosis than men as they start with lower bone density and lose bone mass faster as they age.
ADDIS ABABA, Nov. 2 (Xinhua) -- Ethiopia will host the 13th World Congress on Public Health (WCPH) in April 2012, the Ethiopian Public Health Association (EPHA) said on Wednesday.The meeting will be held on April 23-27 under the theme: "Moving towards Global Health Equity- Opportunities and Treats".Speaking on the 22nd annual meeting of EPHA held here on Wednesday EPHA President Tewabech Bishaw said about 3,000 participants, including public health students from all over the world are expected to take part in the meeting.He said that preparations are well underway to successfully conduct the meeting.
SAN FRANCISCO, Nov. 11 (Xinhua) -- Google will launch its new music service next week, U.S. media reported on Friday.In an emailed invitation, Google said it will hold an event called "These Go to Eleven" next Wednesday in Los Angeles, which is expected to be the debut of Google Music, tech news website The Verge reported.Google is reported to be adding new features over the current version of its music service, such as a MP3 music store with connection to its social network Google+.According to a separate report from technology news site CNET on Friday, Google has not yet got licensing deals with all four of the major labels -- Universal Music Group, Warner Music Group, Sony Music Entertainment and EMI.Google introduced a beta version of its music service called Music Beta in May, enabling users to upload their entire music libraries for free to Google servers and stream songs from any browser or Android-based devices.Since the search giant failed to come to license agreements with major music labels at the time, Music Beta is essentially a massive cloud storage hard drive.
RIO DE JANEIRO, Oct. 21 (Xinhua) -- Representatives from 120 countries attending the WHO's World Conference on Social Determinants of Health on Friday pledged to maintain investments in healthcare to reduce social gap.A statement adopted at the conference urged governments to maintain international collaboration and promote equal access to healthcare regardless of wealth.Brazilian Health Minister Alexandre Padilha said the economic woes in many countries cannot be a reason to "diminish" their social policies."The crisis cannot be an obstacle, instead it must be an opportunity to consolidate social policies," he said.Brazilian Foreign Minister Antonio Patriota said at the conference that health was an issue related to sustainable development, which will be discussed at the UN's Rio +20 Conference in 2012."The conference that ended today is an important step toward Rio +20," he said.
WASHINGTON, Dec. 7 (Xinhua) -- The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida.Their report, published on-line Wednesday in Gynecologic Oncology, suggests that this combination, ixabepilone and sunitinib, might offer a much needed treatment option for women with advanced ovarian cancer.Neither drug is approved for use in ovarian cancer. Ixabepilone is a chemotherapy drug that, like other taxane drugs, targets the microtubules and stops dividing cells from forming a spindle. It has been approved for use in metastatic breast cancer. Sunitinib, approved for use in kidney cancer, belongs to a class of tyrosine kinase inhibitors that stops growth signals from reaching inside cancer cells.When caught at late stages, ovarian cancer is often fatal because it progressively stops responding to the chemotherapy drugs used to treat it."Women die from ovarian cancer because their tumors become resistant to chemotherapy, so a drug that might be able to reduce that resistance -- which may be what this combination of agents is doing -- would be a boon to treatment of this difficult cancer," says study coauthor Gerardo Colon-Otero.The finding also highlights the importance of the role of a molecule, RhoB, that the researchers say is activated by the drug duo. It might be a potential biomarker that may help identify patients who might benefit from such combination therapy, the researchers say.